Patents Assigned to PANOPTES PHARMA GMBH
  • Patent number: 9795590
    Abstract: The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, for use in the treatment of medical conditions which are caused by an adeno virus, HHV (human herpesvirus), VZV (varicella zoster virus), HSV (herpes simplex virus), EBV (Epstein-Barr virus), vaccinia virus, or BK virus.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: October 24, 2017
    Assignee: PANOPTES PHARMA GMBH
    Inventor: Stefan Strobl